Atopic dermatitis is one of the most common causes of chronic discomfort in dogs, causing relentless itch that significantly impairs quality of life.
The welfare impact of canine atopic dermatitis is substantial: the itch-scratch cycle causes chronic discomfort, sleep disruption, and behavioural changes in affected dogs. Secondary bacterial and yeast infections add further pain. Dogs with poorly controlled atopic disease have measurably reduced quality of life compared to healthy dogs. The chronic nature of the condition — requiring lifelong management rather than cure — means that owner commitment and access to effective treatments are critical determinants of welfare outcomes. Modern targeted therapies have transformed welfare outcomes for many atopic dogs, making early appropriate treatment a key welfare priority.